학술논문

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
Document Type
Article
Source
In The Lancet 24-30 June 2023 401(10394):2138-2147
Subject
Primary Research
Articles
Language
ISSN
0140-6736